-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Tevogen Bio Holdings Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Mar 2022 to 31 Mar 2025.
- Tevogen Bio Holdings Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $3,308,063, a 53% decline year-over-year.
- Tevogen Bio Holdings Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $11,998,730, a 47% decline from 2023.
- Tevogen Bio Holdings Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $8,171,118, a 3694% decline from 2022.